top of page
  • yoramlevi6

will the novavax vaccine be a good booster option?


  • "booster campaigns have been undertaken widely in response to failing covid vaccines.

  • they were not supported by clinical outcomes data.

  • the results have been poor and seem to fail on a risk reward basis

  • post omicron, they make even less sense

  • this is the result of undue haste and insufficient testing.

  • therefore the idea of “faster response with novel vaccines next time” idea is one we should abandon, not embrace."




2 weergaven0 opmerkingen

Comments


bottom of page